Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2026
IGCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indogulf Cropsciences reported audited results for Q4 and FY ended March 31, 2026. Consolidated revenue grew 22.3% to Rs 6,272.93 million from Rs 5,128.80 million in FY25, while consolidated PAT increased 27.2% to Rs 400.27 million from Rs 314.72 million. Standalone revenue rose 17.6% to Rs 5,966.76 million with PAT up 19.8% to Rs 386.12 million. The company operates in agrochemicals with one business segment. Statutory auditors issued an unmodified (clean) opinion on both standalone and consolidated financials. The Board also approved appointment of new secretarial auditors (NJ & Associates for 5 years), reappointed cost auditors (Jain Sharma & Associates), and appointed internal auditors (T Jain and Associates) for FY26-27.
Strong growth trajectory with PAT crossing Rs 400 crore on consolidated basis; clean audit opinion supports financial health. Negative operating cash flow (-Rs 117.25 million standalone) may warrant monitoring despite auditor confidence.